Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity? - Wikidata - awgldk - TriplyDB

Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity?

Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity?

http://www.wikidata.org/entity/Q38395652

about

Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma.Expression of Cytokeratin-19 and Thyroperoxidase in Relation to Morphological Features in Non-Neoplastic and Neoplastic Lesions of Thyroid.mTOR signal transduction pathways contribute to TN-C FNIII A1 overexpression by mechanical stress in osteosarcoma cells Galectin-3 Performance in Histologic a Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis.Nodular Thyroid Disease and Thyroid Cancer in the Era of Precision Medicine.HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas.Associations Between Nucleus Size, and Immunohistochemical Galectin-3, Cytokeratine-19 and Hbme-1 Markers in Thyroid Papillary Carcinoma: A Morphometric Analyze.Galectin-3 and HBME-1 Expression on Agarose Cell Blocks from Fine-needle aspirates of Follicular Cell-derived Thyroid Tumors.

P2860

Q34167262-6CA721A9-1F7A-4C2B-9EA5-17139267F3CC Q35644060-1DF3731B-4377-486E-B0A2-D9E35CFEA181 Q37132464-216C0292-3118-468B-B4C0-AF028E152683 Q37604821-E06FC5B7-2C78-4915-97AA-D9695478858B Q38628967-94759AA0-F3BA-420F-841B-BAA4FA1E4D6E Q38673964-B121A34D-1037-4BEA-8EB5-D758472FBEF7 Q39120488-D4799D55-2DDF-41E8-8A66-AE33CD4B6485 Q42363729-9D18F51B-77E6-4BA3-9B21-77BE7640CE66 Q47176207-476B1528-75D4-4EED-AC20-4CD1AE518899 Q49163563-3FBCC8B1-286C-42A4-BFC4-0FE58B1E9239

P2860

Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity?

http://www.wikidata.org/entity/Q38395652

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Combined staining for immunohi ...... he sensitivity or specificity?

@en

type

label

Combined staining for immunohi ...... he sensitivity or specificity?

@en

prefLabel

Combined staining for immunohi ...... he sensitivity or specificity?

@en

P1433

Q38395652-019FE001-50F3-4783-900A-C458964D406C

P1476

Q38395652-046AD0AA-50F6-4E19-8DBE-08C1F63A4904

P2093

Q38395652-276FA1C7-49D0-49DD-AAB0-F004D4ED0D68

Q38395652-6ADBFF05-7196-4F22-A02E-D8ACBE459C03

Q38395652-882EC398-8FAD-4743-A6A1-75D3D5D3658E

Q38395652-8E1B3442-D4DC-4051-AD0E-D38E1E2AB7E6

Q38395652-F49B20F0-CACD-438B-8068-2A72CBB6A91D

P2860

Q38395652-1EB9BC19-0016-4873-9AD0-E97165AEF5D2

Q38395652-2EDD4E48-BC5B-44B9-870D-0AA4AA99597A

Q38395652-556FEEF7-4CB5-48AE-88BB-06A02DB95B1A

Q38395652-62C1CC2B-E618-440D-B293-1D59A1AAB434

Q38395652-665B3EB7-8C4E-4740-99D3-3CDE960A8F3A

Q38395652-6C1F021E-4AB9-462B-A6C7-070F0C8A9B08

Q38395652-6C3AB1F0-4752-4392-BF85-67617F1B594D

Q38395652-75E819B2-4D2F-4007-89EE-B201B9D12E91

Q38395652-76D7FDF9-D7A4-4FFD-80FB-23C3169FCF6B

Q38395652-8824DFF0-7A54-4F3C-A103-220EE99B837A

P304

Q38395652-B6D68213-93C8-42BA-8EAD-713ED5C2C7C8

P31

Q38395652-6B9FC753-CC3C-42B3-8C55-AAD0826D5B39

P356

Q38395652-09FEC39A-18A2-436A-8F44-E54FDC0D8686

P433

Q38395652-045194FE-A3F5-46FA-B5D7-C4D7DFCE23FD

P478

Q38395652-EBF8C8B9-9687-42E2-9AFD-A18A15D2D5D1

P577

Q38395652-79CC91DD-5B0A-453C-9FB6-55D84FB4D736

P5875

Q38395652-0761E57C-7E4D-43AC-8EEB-14EE6E1E7BD1

P698

Q38395652-847924A6-D09B-4E4D-A4C6-D4EBF9324A0D

P921

Q38395652-C4921253-A7F3-4655-8949-967FEED20D64

P356

0300060513490617

P1433

Journal of International Medical Research

P1476

Combined staining for immunohi ...... he sensitivity or specificity?

@en

P2093

Feng Tang

http://www.w3.org/2001/XMLSchema#string

Gang Wu

http://www.w3.org/2001/XMLSchema#string

Jie Wang

http://www.w3.org/2001/XMLSchema#string

Tianyi Li

http://www.w3.org/2001/XMLSchema#string

Zhongwen Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Galectins and cancer

Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland.

Galectin-3 and metastasis.

Pathologic diagnosis of papillary thyroid carcinoma: today and tomorrow.

The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid.

An update on papillary microcarcinoma.

Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy.

Papillary thyroid carcinoma: an update.

Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.

Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastasis in papillary thyroid cancer.

P304

975-983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0300060513490617

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249648143

http://www.w3.org/2001/XMLSchema#string

P698

23857157

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry